GELS
Gelteq Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$0.43
−3.50%Leverage
- Debt / equity
- 0.36x
- Net debt / equity
- 0.36x
- Debt / assets
- 0.25x
- Debt / EBITDA
- -0.96x
- Net debt / EBITDA
- -0.96x
Liquidity & coverage
- Current ratio
- 0.09x
- Quick ratio
- 0.09x
- Cash ratio
- 0.00x
- Interest coverage
- -7.05x
- EBITDA / interest
- -5.91x
- Working capital
- -$3.7M
Cash & dividend
- FCF / debt
- -1.21x
- Cash flow / debt
- -1.08x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025